ATE149840T1 - Behandlung von leberkrebs - Google Patents
Behandlung von leberkrebsInfo
- Publication number
- ATE149840T1 ATE149840T1 AT92911903T AT92911903T ATE149840T1 AT E149840 T1 ATE149840 T1 AT E149840T1 AT 92911903 T AT92911903 T AT 92911903T AT 92911903 T AT92911903 T AT 92911903T AT E149840 T1 ATE149840 T1 AT E149840T1
- Authority
- AT
- Austria
- Prior art keywords
- liver cancer
- treatment
- subject
- effective amount
- therapeutically effective
- Prior art date
Links
- 201000007270 liver cancer Diseases 0.000 title abstract 2
- 208000014018 liver neoplasm Diseases 0.000 title abstract 2
- DNDCVAGJPBKION-DOPDSADYSA-N bombesin Chemical class C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(N)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC=1NC2=CC=CC=C2C=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1NC(=O)CC1)C(C)C)C1=CN=CN1 DNDCVAGJPBKION-DOPDSADYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
- A61K38/105—Bombesin; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/828—Cancer
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/698,681 US6083915A (en) | 1991-05-10 | 1991-05-10 | Method for treating liver cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE149840T1 true ATE149840T1 (de) | 1997-03-15 |
Family
ID=24806255
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT92911903T ATE149840T1 (de) | 1991-05-10 | 1992-05-11 | Behandlung von leberkrebs |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6083915A (de) |
| EP (1) | EP0588873B1 (de) |
| JP (2) | JP3514754B2 (de) |
| AT (1) | ATE149840T1 (de) |
| CA (1) | CA2109206A1 (de) |
| DE (1) | DE69218200T2 (de) |
| DK (1) | DK0588873T3 (de) |
| ES (1) | ES2101100T3 (de) |
| GR (1) | GR3023645T3 (de) |
| HK (1) | HK1006947A1 (de) |
| IE (1) | IE921508A1 (de) |
| WO (1) | WO1992020363A1 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100410274C (zh) * | 2006-04-21 | 2008-08-13 | 暨南大学 | 特异性抗人肝癌噬菌体单链抗体HscFv 4－16基因及其应用 |
| KR100814118B1 (ko) * | 2006-10-17 | 2008-03-18 | (주)국광플랜 | 문자나 도형 광고용 간판 |
| KR100814120B1 (ko) * | 2006-10-17 | 2008-03-18 | (주)국광플랜 | 측광 및 후광을 이용한 문자나 도형 광고용 간판 |
| KR20090119966A (ko) * | 2007-03-01 | 2009-11-23 | 바이엘 쉐링 파마 악티엔게젤샤프트 | 진단 영상화제로서의 18ｆ 플루오로-벤조일 표지된 생물학적 활성 화합물, 벤조트리아졸-1-일옥시-벤조일, 2,5-디옥소-피롤리딘-1-일옥시)벤조일 및 트리메틸암모니오-벤조일 전구체 |
| EP2310028B1 (de) | 2008-06-12 | 2016-11-16 | Ipsen Bioinnovation Limited | Fusionsproteine zur Verwendung bei der Behandlung von Akromegalie |
| WO2009150470A2 (en) | 2008-06-12 | 2009-12-17 | Syntaxin Limited | Suppression of cancers |
| GB0820970D0 (en) | 2008-11-17 | 2008-12-24 | Syntaxin Ltd | Suppression of cancer |
| EP2198878A1 (de) | 2008-12-18 | 2010-06-23 | University Of Miami | Polypeptide Bombesinantagonisten |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU618029B2 (en) * | 1987-11-02 | 1991-12-12 | Imperial Chemical Industries Plc | Polypeptide compounds |
| GB8813356D0 (en) * | 1988-06-06 | 1988-07-13 | Ici Plc | Polypeptide compounds |
| WO1991004040A1 (en) * | 1989-09-15 | 1991-04-04 | Biomeasure, Inc. | Treatment of colon cancer |
-
1991
- 1991-05-10 US US07/698,681 patent/US6083915A/en not_active Expired - Fee Related
-
1992
- 1992-05-11 JP JP51116992A patent/JP3514754B2/ja not_active Expired - Fee Related
- 1992-05-11 WO PCT/US1992/003916 patent/WO1992020363A1/en not_active Ceased
- 1992-05-11 EP EP92911903A patent/EP0588873B1/de not_active Expired - Lifetime
- 1992-05-11 CA CA002109206A patent/CA2109206A1/en not_active Abandoned
- 1992-05-11 DK DK92911903.0T patent/DK0588873T3/da active
- 1992-05-11 HK HK98106184A patent/HK1006947A1/en not_active IP Right Cessation
- 1992-05-11 DE DE69218200T patent/DE69218200T2/de not_active Expired - Fee Related
- 1992-05-11 AT AT92911903T patent/ATE149840T1/de not_active IP Right Cessation
- 1992-05-11 ES ES92911903T patent/ES2101100T3/es not_active Expired - Lifetime
- 1992-07-01 IE IE150892A patent/IE921508A1/en not_active Application Discontinuation
-
1997
- 1997-05-30 GR GR970401291T patent/GR3023645T3/el unknown
-
2003
- 2003-03-20 JP JP2003078758A patent/JP2004002331A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| ES2101100T3 (es) | 1997-07-01 |
| DE69218200D1 (de) | 1997-04-17 |
| EP0588873A4 (de) | 1995-01-11 |
| EP0588873A1 (de) | 1994-03-30 |
| GR3023645T3 (en) | 1997-08-29 |
| JP3514754B2 (ja) | 2004-03-31 |
| JP2004002331A (ja) | 2004-01-08 |
| DK0588873T3 (da) | 1997-09-15 |
| IE921508A1 (en) | 1992-11-18 |
| US6083915A (en) | 2000-07-04 |
| JPH06507633A (ja) | 1994-09-01 |
| DE69218200T2 (de) | 1997-09-25 |
| WO1992020363A1 (en) | 1992-11-26 |
| EP0588873B1 (de) | 1997-03-12 |
| HK1006947A1 (en) | 1999-03-26 |
| CA2109206A1 (en) | 1992-11-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA26213C2 (uk) | Засіб для профілактики та лікуваhhя остеопорозу та фармацевтичhа композиція hа їх осhові | |
| ATE105482T1 (de) | Behandlung von krebs mit somatostatin und mit analogen davon. | |
| DE3779149D1 (de) | Galanthamin oder dessen analoge zur behandlung der alzheimerschen krankheit. | |
| DE3888378D1 (de) | Behandlung von Prostatacarcinoma mit 17-beta-n-monosubstituierten-Carbamoyl-4-aza-5-alpha-Androst-1-en-3-onen. | |
| NO910340L (no) | Topiske preparater for behandling av menneskenegler. | |
| KR950700749A (ko) | 2'-할로메틸리덴 유도체와 S-기 또는 M-기 특이성 항종양제를 사용하는 결합치료에 의한 암치료 방법(Method of treating cancer by conjunctive therapy with 2'-halomethylidene derivatives and a S-phase or M phase specific antineoplastic agent) | |
| DE69426334D1 (de) | Parenterales Busulfan zur Behandlung von malignen Krankheiten | |
| PL310476A1 (en) | Application of lamotrigin in treating neuro-aids diseases | |
| DE68907423D1 (de) | Behandlung der akne. | |
| DK71387D0 (da) | Terapeutisk middel til behandling af psoriasis | |
| DE3650620D1 (de) | Behandlungsverfahren kataboler dysfunktion | |
| DE69224173D1 (de) | Behandlung von lignocellulosischen Materialien | |
| DE3888994D1 (de) | Behandlung von androgener Alopecia mit 17-beta-n-mono-substituierten-carbamoyl-4-aza-5-alpha-androst-1-en-3-onen. | |
| DE69302439D1 (de) | Topisches Präparat zur Verhütung oder Behandlung der Akne Vulgaris | |
| DE69229670D1 (de) | Bodenbehandlungsmaschine | |
| DE69218200D1 (de) | Behandlung von leberkrebs | |
| SE9601395D0 (sv) | New therapeutic treatment 1 | |
| DE69103693D1 (de) | Behandlung von unterirdischen Formationen. | |
| ATE217191T1 (de) | Verwendung von phanquinon zur behandlung von alzheimer's krankheit | |
| GR3023021T3 (en) | Synergising association having an antagonist effect on nk1 and nk2 receptors. | |
| NO993627L (no) | Anvendelse av en forbindelse for fremstilling av et legemiddel | |
| DE69325141D1 (de) | Behandlung von lignozellulosehaltigen Materialien | |
| GEP20012511B (en) | Method for Lowering Level of Lipoproteins (a) in Serum or Plasma of Mammals, Method for Treatment of Peripheral Vascular Diseases or Restenosis | |
| ATE181240T1 (de) | Verwendung von somatostatinanalogen zur behandlung von melanomen | |
| ATE293972T1 (de) | Behandlung von chronischen schmerzen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |